IMARC Group’s latest report, titled “Coagulation Analyzer Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, the global coagulation analyzer market size reached US$ 4.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 7.8 Billion by 2027, exhibiting a growth rate (CAGR) of 8% during 2022-2027.
Coagulation, also known as hematology, represents a process that enables the blood to form a clot to cure a wound. Physicians primarily use coagulation analyzers for classifying and quantifying blood cells. Various types of tests, such as APTT, PT, ACT, etc., are carried out to evaluate blood clotting function in patients. Most hematology analyzers are capable of delivering information about corpuscular data, platelet counts, hemoglobin in red blood cells (RBCs), and hematocrit levels. However, some new machines have been designed to measure two specialized cell types, which include immature white cells and nucleated RBCs. As a result, coagulation analyzers find widespread applications across clinical laboratories, hospitals, and diagnostic centers.
Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/coagulation-analyzer-market/requestsample
Coagulation Analyzer Market Demand:
Several technological advancements and the introduction of innovative tests have led to an increase in the quality and efficiency of hemostasis laboratories, which are among the primary factors driving the coagulation analyzer market. Besides this, the escalating demand for these machines, owing to the rising population suffering from blood disorders and lifestyle diseases, is further augmenting the market growth. Moreover, the growing popularity of coagulation analyzers, as they possess high throughput, flexibility, and reliability, provide improved accuracy and precision, and easy-to-use advanced software equipped with in-built graphs and calibration curves, is also catalyzing the global market. Apart from this, the increasing number of diagnostic centers and research institutes being established across countries are acting as significant growth-inducing factors. Furthermore, the development of the Xprecia Stride device that delivers fast and efficient prothrombin time testing (PT/INR) results for point-of-care (POC) monitoring is anticipated to propel the coagulation analyzer market over the forecasted period.
Competitive Landscape with Keyplayers:
Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/coagulation-analyzer-market
Key Market Segmentation:
Breakup by Testing Type:
Breakup by Product Type:
Breakup by Technology Type:
Breakup by End User:
Breakup by Region:
Key Highlights of the Report:
Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Browse More Research Reports:
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800